 | • レポートコード：MRC2-11QY07617 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は代謝型グルタミン酸受容体5のグローバル市場について調査・分析したレポートです。種類別（Alloswitch-1、BMS-952048、BMS-955829、Dipraglurant ER、その他）市場規模、用途別（大うつ病性障害、アルコール依存症、アルツハイマー病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別代謝型グルタミン酸受容体5の競争状況、市場シェア ・世界の代謝型グルタミン酸受容体5市場：種類別市場規模 2015年-2020年（Alloswitch-1、BMS-952048、BMS-955829、Dipraglurant ER、その他） ・世界の代謝型グルタミン酸受容体5市場：種類別市場規模予測 2021年-2026年（Alloswitch-1、BMS-952048、BMS-955829、Dipraglurant ER、その他） ・世界の代謝型グルタミン酸受容体5市場：用途別市場規模 2015年-2020年（大うつ病性障害、アルコール依存症、アルツハイマー病、その他） ・世界の代謝型グルタミン酸受容体5市場：用途別市場規模予測 2021年-2026年（大うつ病性障害、アルコール依存症、アルツハイマー病、その他） ・北米の代謝型グルタミン酸受容体5市場分析：米国、カナダ ・ヨーロッパの代謝型グルタミン酸受容体5市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの代謝型グルタミン酸受容体5市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の代謝型グルタミン酸受容体5市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの代謝型グルタミン酸受容体5市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Addex Therapeutics Ltd、Aevi Genomic Medicine Inc、Bristol-Myers Squibb Company、Eisai Co Ltd、Eli Lilly and Company、Heptares Therapeutics Ltd、Johnson & Johnson、Merz Pharma GmbH & Co KgaA、Novartis AG、Richter Gedeon Nyrt、Sumitomo Dainippon Pharma Co Ltd、Toray Industries Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Metabotropic Glutamate Receptor 5 Market
The global Metabotropic Glutamate Receptor 5 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Metabotropic Glutamate Receptor 5 Scope and Market Size
Metabotropic Glutamate Receptor 5 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabotropic Glutamate Receptor 5 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Metabotropic Glutamate Receptor 5 market is segmented into
Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others
Segment by Application, the Metabotropic Glutamate Receptor 5 market is segmented into
Major Depressive Disorder
Alcohol Assiction
Alzheimer’s Disease
Others
Regional and Country-level Analysis
The Metabotropic Glutamate Receptor 5 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Metabotropic Glutamate Receptor 5 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Metabotropic Glutamate Receptor 5 Market Share Analysis
Metabotropic Glutamate Receptor 5 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Metabotropic Glutamate Receptor 5 business, the date to enter into the Metabotropic Glutamate Receptor 5 market, Metabotropic Glutamate Receptor 5 product introduction, recent developments, etc.
The major vendors covered:
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc
1 Study Coverage
1.1 Metabotropic Glutamate Receptor 5 Product Introduction
1.2 Market Segments
1.3 Key Metabotropic Glutamate Receptor 5 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type
1.4.2 Alloswitch-1
1.4.3 BMS-952048
1.4.4 BMS-955829
1.4.5 Dipraglurant ER
1.4.6 Others
1.5 Market by Application
1.5.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application
1.5.2 Major Depressive Disorder
1.5.3 Alcohol Assiction
1.5.4 Alzheimer’s Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 5 Market Size, Estimates and Forecasts
2.1.1 Global Metabotropic Glutamate Receptor 5 Revenue 2015-2026
2.1.2 Global Metabotropic Glutamate Receptor 5 Sales 2015-2026
2.2 Global Metabotropic Glutamate Receptor 5, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Metabotropic Glutamate Receptor 5 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Metabotropic Glutamate Receptor 5 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Metabotropic Glutamate Receptor 5 Competitor Landscape by Players
3.1 Metabotropic Glutamate Receptor 5 Sales by Manufacturers
3.1.1 Metabotropic Glutamate Receptor 5 Sales by Manufacturers (2015-2020)
3.1.2 Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturers (2015-2020)
3.2 Metabotropic Glutamate Receptor 5 Revenue by Manufacturers
3.2.1 Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2015-2020)
3.2.2 Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Metabotropic Glutamate Receptor 5 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 5 Revenue in 2019
3.2.5 Global Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Metabotropic Glutamate Receptor 5 Price by Manufacturers
3.4 Metabotropic Glutamate Receptor 5 Manufacturing Base Distribution, Product Types
3.4.1 Metabotropic Glutamate Receptor 5 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Metabotropic Glutamate Receptor 5 Product Type
3.4.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 5 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metabotropic Glutamate Receptor 5 Market Size by Type (2015-2020)
4.1.1 Global Metabotropic Glutamate Receptor 5 Sales by Type (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type (2015-2020)
4.1.3 Metabotropic Glutamate Receptor 5 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Metabotropic Glutamate Receptor 5 Market Size Forecast by Type (2021-2026)
4.2.1 Global Metabotropic Glutamate Receptor 5 Sales Forecast by Type (2021-2026)
4.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Type (2021-2026)
4.2.3 Metabotropic Glutamate Receptor 5 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Metabotropic Glutamate Receptor 5 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Metabotropic Glutamate Receptor 5 Market Size by Application (2015-2020)
5.1.1 Global Metabotropic Glutamate Receptor 5 Sales by Application (2015-2020)
5.1.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application (2015-2020)
5.1.3 Metabotropic Glutamate Receptor 5 Price by Application (2015-2020)
5.2 Metabotropic Glutamate Receptor 5 Market Size Forecast by Application (2021-2026)
5.2.1 Global Metabotropic Glutamate Receptor 5 Sales Forecast by Application (2021-2026)
5.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Application (2021-2026)
5.2.3 Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Metabotropic Glutamate Receptor 5 by Country
6.1.1 North America Metabotropic Glutamate Receptor 5 Sales by Country
6.1.2 North America Metabotropic Glutamate Receptor 5 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Metabotropic Glutamate Receptor 5 Market Facts & Figures by Type
6.3 North America Metabotropic Glutamate Receptor 5 Market Facts & Figures by Application
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 5 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country
7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Metabotropic Glutamate Receptor 5 Market Facts & Figures by Type
7.3 Europe Metabotropic Glutamate Receptor 5 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 5 by Region
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Region
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Metabotropic Glutamate Receptor 5 Market Facts & Figures by Type
8.3 Asia Pacific Metabotropic Glutamate Receptor 5 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 5 by Country
9.1.1 Latin America Metabotropic Glutamate Receptor 5 Sales by Country
9.1.2 Latin America Metabotropic Glutamate Receptor 5 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Metabotropic Glutamate Receptor 5 Market Facts & Figures by Type
9.3 Central & South America Metabotropic Glutamate Receptor 5 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 5 by Country
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Facts & Figures by Type
10.3 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Facts & Figures by Application
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Corporation Information
11.2.2 Aevi Genomic Medicine Inc Description and Business Overview
11.2.3 Aevi Genomic Medicine Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Products Offered
11.2.5 Aevi Genomic Medicine Inc Related Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Corporation Information
11.3.2 Bristol-Myers Squibb Company Description and Business Overview
11.3.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Products Offered
11.3.5 Bristol-Myers Squibb Company Related Developments
11.4 Eisai Co Ltd
11.4.1 Eisai Co Ltd Corporation Information
11.4.2 Eisai Co Ltd Description and Business Overview
11.4.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Products Offered
11.4.5 Eisai Co Ltd Related Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Description and Business Overview
11.5.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Products Offered
11.5.5 Eli Lilly and Company Related Developments
11.6 Heptares Therapeutics Ltd
11.6.1 Heptares Therapeutics Ltd Corporation Information
11.6.2 Heptares Therapeutics Ltd Description and Business Overview
11.6.3 Heptares Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products Offered
11.6.5 Heptares Therapeutics Ltd Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Description and Business Overview
11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Products Offered
11.7.5 Johnson & Johnson Related Developments
11.8 Merz Pharma GmbH & Co KgaA
11.8.1 Merz Pharma GmbH & Co KgaA Corporation Information
11.8.2 Merz Pharma GmbH & Co KgaA Description and Business Overview
11.8.3 Merz Pharma GmbH & Co KgaA Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Products Offered
11.8.5 Merz Pharma GmbH & Co KgaA Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Metabotropic Glutamate Receptor 5 Products Offered
11.9.5 Novartis AG Related Developments
11.10 Richter Gedeon Nyrt
11.10.1 Richter Gedeon Nyrt Corporation Information
11.10.2 Richter Gedeon Nyrt Description and Business Overview
11.10.3 Richter Gedeon Nyrt Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Products Offered
11.10.5 Richter Gedeon Nyrt Related Developments
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Description and Business Overview
11.1.3 Addex Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products Offered
11.1.5 Addex Therapeutics Ltd Related Developments
11.12 Toray Industries Inc
11.12.1 Toray Industries Inc Corporation Information
11.12.2 Toray Industries Inc Description and Business Overview
11.12.3 Toray Industries Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Toray Industries Inc Products Offered
11.12.5 Toray Industries Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Metabotropic Glutamate Receptor 5 Market Estimates and Projections by Region
12.1.1 Global Metabotropic Glutamate Receptor 5 Sales Forecast by Regions 2021-2026
12.1.2 Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Regions 2021-2026
12.2 North America Metabotropic Glutamate Receptor 5 Market Size Forecast (2021-2026)
12.2.1 North America: Metabotropic Glutamate Receptor 5 Sales Forecast (2021-2026)
12.2.2 North America: Metabotropic Glutamate Receptor 5 Revenue Forecast (2021-2026)
12.2.3 North America: Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2021-2026)
12.3 Europe Metabotropic Glutamate Receptor 5 Market Size Forecast (2021-2026)
12.3.1 Europe: Metabotropic Glutamate Receptor 5 Sales Forecast (2021-2026)
12.3.2 Europe: Metabotropic Glutamate Receptor 5 Revenue Forecast (2021-2026)
12.3.3 Europe: Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Metabotropic Glutamate Receptor 5 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Metabotropic Glutamate Receptor 5 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Metabotropic Glutamate Receptor 5 Market Size Forecast by Region (2021-2026)
12.5 Latin America Metabotropic Glutamate Receptor 5 Market Size Forecast (2021-2026)
12.5.1 Latin America: Metabotropic Glutamate Receptor 5 Sales Forecast (2021-2026)
12.5.2 Latin America: Metabotropic Glutamate Receptor 5 Revenue Forecast (2021-2026)
12.5.3 Latin America: Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Metabotropic Glutamate Receptor 5 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Metabotropic Glutamate Receptor 5 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Metabotropic Glutamate Receptor 5 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Metabotropic Glutamate Receptor 5 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Metabotropic Glutamate Receptor 5 Market Segments
Table 2. Ranking of Global Top Metabotropic Glutamate Receptor 5 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Alloswitch-1
Table 5. Major Manufacturers of BMS-952048
Table 6. Major Manufacturers of BMS-955829
Table 7. Major Manufacturers of Dipraglurant ER
Table 8. Major Manufacturers of Others
Table 9. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Metabotropic Glutamate Receptor 5 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Metabotropic Glutamate Receptor 5 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Regions (2015-2020)
Table 13. Global Metabotropic Glutamate Receptor 5 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Metabotropic Glutamate Receptor 5 Sales Share by Manufacturers (2015-2020)
Table 16. Global Metabotropic Glutamate Receptor 5 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Metabotropic Glutamate Receptor 5 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 5 as of 2019)
Table 18. Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Metabotropic Glutamate Receptor 5 Price (2015-2020) (USD/Pcs)
Table 21. Metabotropic Glutamate Receptor 5 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Metabotropic Glutamate Receptor 5 Product Type
Table 23. Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 5 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Metabotropic Glutamate Receptor 5 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Metabotropic Glutamate Receptor 5 Sales Share by Type (2015-2020)
Table 27. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Metabotropic Glutamate Receptor 5 Revenue Share by Type (2015-2020)
Table 29. Metabotropic Glutamate Receptor 5 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Metabotropic Glutamate Receptor 5 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Metabotropic Glutamate Receptor 5 Sales Share by Application (2015-2020)
Table 32. North America Metabotropic Glutamate Receptor 5 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2015-2020)
Table 34. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2015-2020)
Table 36. North America Metabotropic Glutamate Receptor 5 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2015-2020)
Table 38. North America Metabotropic Glutamate Receptor 5 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2015-2020)
Table 40. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2015-2020)
Table 42. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2015-2020)
Table 44. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2015-2020)
Table 46. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2015-2020)
Table 56. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Metabotropic Glutamate Receptor 5 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2015-2020)
Table 62. Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2015-2020)
Table 72. Addex Therapeutics Ltd Corporation Information
Table 73. Addex Therapeutics Ltd Description and Major Businesses
Table 74. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Addex Therapeutics Ltd Product
Table 76. Addex Therapeutics Ltd Recent Development
Table 77. Aevi Genomic Medicine Inc Corporation Information
Table 78. Aevi Genomic Medicine Inc Description and Major Businesses
Table 79. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Aevi Genomic Medicine Inc Product
Table 81. Aevi Genomic Medicine Inc Recent Development
Table 82. Bristol-Myers Squibb Company Corporation Information
Table 83. Bristol-Myers Squibb Company Description and Major Businesses
Table 84. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bristol-Myers Squibb Company Product
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Eisai Co Ltd Corporation Information
Table 88. Eisai Co Ltd Description and Major Businesses
Table 89. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Eisai Co Ltd Product
Table 91. Eisai Co Ltd Recent Development
Table 92. Eli Lilly and Company Corporation Information
Table 93. Eli Lilly and Company Description and Major Businesses
Table 94. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Eli Lilly and Company Product
Table 96. Eli Lilly and Company Recent Development
Table 97. Heptares Therapeutics Ltd Corporation Information
Table 98. Heptares Therapeutics Ltd Description and Major Businesses
Table 99. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Heptares Therapeutics Ltd Product
Table 101. Heptares Therapeutics Ltd Recent Development
Table 102. Johnson & Johnson Corporation Information
Table 103. Johnson & Johnson Description and Major Businesses
Table 104. Johnson & Johnson Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Johnson & Johnson Product
Table 106. Johnson & Johnson Recent Development
Table 107. Merz Pharma GmbH & Co KgaA Corporation Information
Table 108. Merz Pharma GmbH & Co KgaA Description and Major Businesses
Table 109. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Merz Pharma GmbH & Co KgaA Product
Table 111. Merz Pharma GmbH & Co KgaA Recent Development
Table 112. Novartis AG Corporation Information
Table 113. Novartis AG Description and Major Businesses
Table 114. Novartis AG Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Novartis AG Product
Table 116. Novartis AG Recent Development
Table 117. Richter Gedeon Nyrt Corporation Information
Table 118. Richter Gedeon Nyrt Description and Major Businesses
Table 119. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Richter Gedeon Nyrt Product
Table 121. Richter Gedeon Nyrt Recent Development
Table 122. Sumitomo Dainippon Pharma Co Ltd Corporation Information
Table 123. Sumitomo Dainippon Pharma Co Ltd Description and Major Businesses
Table 124. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Sumitomo Dainippon Pharma Co Ltd Product
Table 126. Sumitomo Dainippon Pharma Co Ltd Recent Development
Table 127. Toray Industries Inc Corporation Information
Table 128. Toray Industries Inc Description and Major Businesses
Table 129. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Toray Industries Inc Product
Table 131. Toray Industries Inc Recent Development
Table 132. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 133. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Regions (2021-2026)
Table 134. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 135. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Regions (2021-2026)
Table 136. North America: Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. North America: Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Europe: Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Europe: Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Asia Pacific: Metabotropic Glutamate Receptor 5 Sales Forecast by Region (2021-2026) (K Pcs)
Table 141. Asia Pacific: Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 142. Latin America: Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Latin America: Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Middle East and Africa: Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. Middle East and Africa: Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Metabotropic Glutamate Receptor 5 Players
Table 150. Metabotropic Glutamate Receptor 5 Customers List
Table 151. Metabotropic Glutamate Receptor 5 Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 5 Product Picture
Figure 2. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020 & 2026
Figure 3. Alloswitch-1 Product Picture
Figure 4. BMS-952048 Product Picture
Figure 5. BMS-955829 Product Picture
Figure 6. Dipraglurant ER Product Picture
Figure 7. Others Product Picture
Figure 8. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020 & 2026
Figure 9. Major Depressive Disorder
Figure 10. Alcohol Assiction
Figure 11. Alzheimer's Disease
Figure 12. Others
Figure 13. Metabotropic Glutamate Receptor 5 Report Years Considered
Figure 14. Global Metabotropic Glutamate Receptor 5 Market Size 2015-2026 (US$ Million)
Figure 15. Global Metabotropic Glutamate Receptor 5 Sales 2015-2026 (K Pcs)
Figure 16. Global Metabotropic Glutamate Receptor 5 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2015-2020)
Figure 18. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region in 2019
Figure 19. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2015-2020)
Figure 20. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region in 2019
Figure 21. Global Metabotropic Glutamate Receptor 5 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Metabotropic Glutamate Receptor 5 Revenue in 2019
Figure 23. Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2015-2020)
Figure 25. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2019
Figure 26. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2015-2020)
Figure 27. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type in 2019
Figure 28. Global Metabotropic Glutamate Receptor 5 Market Share by Price Range (2015-2020)
Figure 29. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2015-2020)
Figure 30. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2019
Figure 31. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2015-2020)
Figure 32. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application in 2019
Figure 33. North America Metabotropic Glutamate Receptor 5 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2019
Figure 36. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2019
Figure 37. U.S. Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Metabotropic Glutamate Receptor 5 Market Share by Type in 2019
Figure 42. North America Metabotropic Glutamate Receptor 5 Market Share by Application in 2019
Figure 43. Europe Metabotropic Glutamate Receptor 5 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2019
Figure 46. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2019
Figure 47. Germany Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Metabotropic Glutamate Receptor 5 Market Share by Type in 2019
Figure 58. Europe Metabotropic Glutamate Receptor 5 Market Share by Application in 2019
Figure 59. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Region in 2019
Figure 62. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Market Share by Region in 2019
Figure 63. China Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Metabotropic Glutamate Receptor 5 Market Share by Type in 2019
Figure 86. Asia Pacific Metabotropic Glutamate Receptor 5 Market Share by Application in 2019
Figure 87. Latin America Metabotropic Glutamate Receptor 5 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2019
Figure 90. Latin America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2019
Figure 91. Mexico Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Metabotropic Glutamate Receptor 5 Market Share by Type in 2019
Figure 98. Latin America Metabotropic Glutamate Receptor 5 Market Share by Application in 2019
Figure 99. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2019
Figure 103. Turkey Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Metabotropic Glutamate Receptor 5 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Share by Type in 2019
Figure 110. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Share by Application in 2019
Figure 111. North America Metabotropic Glutamate Receptor 5 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Metabotropic Glutamate Receptor 5 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Metabotropic Glutamate Receptor 5 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Metabotropic Glutamate Receptor 5 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Metabotropic Glutamate Receptor 5 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Metabotropic Glutamate Receptor 5 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
代謝型グルタミン酸受容体7の世界市場（～2026年） Market Analysis and Insights: Global Metabotropic Glutamate Receptor 7 Market The global Metabotropic Glutamate Receptor 7 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metabotropic Glutamate Receptor 7 Scope and Mar…- グルタミン酸ナトリウムの世界市場（～2026年） Sodium glutamate commonly referred as MSG, also known as monosodium glutamate is sodium salt of glutamic acid. Sodium glutamate is available in the market through various trade names such as third spice, accent, ajinomoto and vetsin among others. The market for sodium glutamate was mainly driven by …
- グルタミン酸カルボキシペプチダーゼ2の世界市場（～2026年） Market Analysis and Insights: Global Glutamate Carboxypeptidase 2 Market The global Glutamate Carboxypeptidase 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glutamate Carboxypeptidase 2 Scope and Market Size Glutam…
- グルタメート界面活性剤の世界市場（～2026年） Market Analysis and Insights: Global Glutamate Surfactants Market The global Glutamate Surfactants market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glutamate Surfactants Scope and Market Size Glutamate Surfactants marke…
- グルタミン酸・グルタミン酸ナトリウムの世界市場（～2026年） Market Analysis and Insights: Global Glutamic Acid and Monosodium Glutamate Market The global Glutamic Acid and Monosodium Glutamate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glutamic Acid and Monosodium Glutamat…